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Conclusions: Since FIF technique was simple and achieved reasonable 
dosimetric results, it is recommended for treating right breast cancer. 
Because of the highly conformal and homogenous target dose, HTis 
recommended for breast cancer patients with SCF lymph nodes 
involvement and patients with chest wall target crossed midline 
and/or with concave chest wall.Both tomotherapy techniques were 
more favourable for left breast cancer as good target dosimetry was 
maintained. The advantages of TomoDirect might outweigh its inferior 
treatment delivery efficiency and provide an alternative treatment 
strategy only for patients require maximum sparing of OARs.  
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Purpose/Objective: To compare RapidArc (RA), 3D conformal (3D-
CRT) and conventional IMRT planning for non-metastatic gastric 
cancer using dosimetric analysis. 
Materials and Methods: In a retrospective study, ten patients 
previously treated with 3D-CRT at our institution were re-planned 
using IMRT and RapidArc techniques. Site based institutional dose 
volume constraints were used to guide plan optimization, based on 
risk of normal tissue complication probability. 3D- CRT plans with 
three to five-fields were compared with IMRT plans containing up to 
nine dynamic fields and VMAT plans with two arc therapy beams. 
Target coverage was analyzed using V95, conformity and homogeneity 
indices and DVH parameters (D1, D2, D50, D98, D99). Clinical criteria 
of organs at risk (OAR) tolerance doses were based upon D33 and D66, 
but for plan comparison, further DVH metrics were assessed. 
Results:  
Median values are reported (Table 1). 
  
 All plans met OAR dose volume constraints. For clinical PTV criteria: 
V95 ≥ 95%, all RA plans(10/10), 9/10 IMRT and 8/10 3D-CRT plans met 
this constraint. PTV coverage was superior with RA. V95 values: RA 
98.84, IMRT 98.29, 3D-CRT 97.18. PTV dose conformity was 
comparable between RA and IMRT but statistically significantly 
inferior for 3D-CRT (p= 0.02). 3D-CRT plans were designed to avoid 
kidneys where possible and for each kidney provided superior 
avoidance with respect to clinical criteria (D33, D66) when compared 
to RA and IMRT. For liver, D33 and D66 were lower with RA. All 3 
techniques provide comparable small bowel sparing. Mean values for 
Monitor Units were considerably less for RA (371) and 3D-CRT (475) 
than IMRT (1639). 
Conclusions: RA provides comparable PTV conformity and OAR 
avoidance to IMRT with less MU’s which may translate to more 
favorable treatment times. 3D-CRT can provide OAR sparing superior 
to IMRT and RA but at the expense of PTV conformity. 
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Purpose/Objective: To investigate the capability of IMRT to improve 
lung and heart sparing in treatment planning for oesophageal cancer 
and subsequently the feasibility for a simultaneously integrated boost 
(SIB) for dose escalation. 
Materials and Methods: Conventional 4-field 3D conformal 
radiotherapy (3DCRT) planning was compared with four different IMRT 
planning techniques: 5 or 7 equi-angled beams, arranged as starting 
from gantry 0º (AP) or 180º (PA), for 26 patients with oesophageal 
cancer. Prescription dose to the primary tumour and involved lymph 
nodes was 28×1.8Gy = 50.4Gy, applied as a planning objective to the 
PTV: V95%PTV≥95% (and V105%PTV≤2%). PTV margins were 1.5 cm. 
Constraints for organs at risk (OAR) were V45Gy<50% for the heart, 
mean lung dose (Dmeanlung) <16Gy, and V20Gy<30% for lungs and both 
kidneys, whereas lung sparing was considered dominant over heart 
sparing. Dose distributions were compared regarding mean dose to the 
PTV (DmeanPTV), conformity index (CI) of the 95% isodose, heart and 
lung dose, as well as the total number of objective or constraint 
violations encountered for each planning technique. Subsequently, the 
most suitable IMRT technique was applied to plan an integrated boost 
to the primary tumour of an additional 28×0.4Gy = 11.2Gy, without 
compromising the original OAR constraints. PTVboost margins around 
the primary tumour were 1 cm. 
Results: Planning results are summarized in Table 1 (mean ± SD). PTV 
volume was on average 506 ± 253 cc. Boost volume (PTVboost) was on 
average 190 ± 87 cc. IMRT resulted in a significantly more conformal 
dose to the target volume than 3DCRT. Heart dose was significantly 
lower when using IMRT. Mean lung dose and V20Gylung were significantly 
lower for IMRT plans, at the expense of higher lung volumes receiving 
a low dose level (V5Gylung). Despite small differences between the four 
IMRT techniques, the 7 beam PA arrangement was considered the 
most suitable configuration. Including an integrated boost using this 
technique resulted in a small but acceptable increase in heart and 
lung dose. Mean dose to the PTV was much larger and slightly less 
conformal, whereas conformity of the boost dose to PTVboost was 
excellent. 
TABLE 1 3DCRT IMRT 5-AP 
IMRT 5-
PA 
IMRT 7-
AP 
IMRT 7-
PA 
IMRT + 
SIB 
DmeanPTV [Gy] 50.84 ± 0.36 
50.66 ± 
0.35 
50.68 ± 
0.28 
50.62 ± 
0.37 
50.62 ± 
0.29 
56.59 ± 
1.39 
CI [-] 1.41 ± 0.12 
1.08 ± 
0.05 
1.09 ± 
0.07 
1.07 ± 
0.06 
1.07 ± 
0.06 
1.16 ± 
0.06 
DmeanPTV boost [Gy] - - - - - 62.32 ± 0.37 
CIboost [-] - - - - - 1.05 ± 0.04 
# objective
violations [-] 11 3 3 4 1 - 
V45Gyheart [%] 14.6 ± 5.9 
10.8 ± 
4.8 
10.7 ± 
4.7 
10.6 ± 
4.5 
10.5 ± 
4.5 
11.6 ± 
4.8 
Dmeanlung [Gy] 12.66 ± 3.68 
11.60 ± 
3.17 
11.53 ± 
3.18 
11.24 ± 
2.91 
11.32 ± 
3.00 
12.21 ± 
3.31 
V20Gylung [%] 24.9 ± 5.8 
16.8 ± 
6.5 
14.9 ± 
6.5 
14.7 ± 
5.9 
14.5 ± 
6.7 
17.1 ± 
6.2 
V10Gylung [%] 44.5 ± 16.3 
44.9 ± 
13.9 
47.1 ± 
14.4 
45.6 ± 
11.7 
46.8 ± 
12.6 
50.4 ± 
15.2 
V5Gylung [%] 59.2 ± 19.2 
69.9 ± 
18.4 
69.5 ± 
18.9 
68.7 ± 
17.8 
68.1 ± 
17.8 
71.1 ± 
20.4 
# constraint
violations [-] 9 3 3 2 1 1 
 
Conclusions: IMRT planning with an integrated boost for oesophageal 
cancer is feasible with a relatively simple and straightforward 
technique, and is capable of producing a conformal dose distribution 
with adequate heart and lung sparing.  
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Purpose/Objective: To compare prone position (PP) with the standard 
supine position (SP) in women undergoing tangential fields WBRT after 
breast conserving surgery. 
Materials and Methods: From September 2010 we simulated selected 
patients in the two positions according to volume of breast, mobility 
of patient and tolerance of the patient in PP. In SP deep inspiration 
breath hold was performed when treating the left breast. Ipsilateral 
breast PTV, heart and ipsilateral lung were contoured and the dose 
distribution were compared using dose-volume histograms (DVH). PTV 
receiving at least 90% of the prescription dose (V90%) was assessed in 
SP and PP. Statistical significance were calculated using the paired 
Student's t-test. 
Results: 
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 One hundred nine patients were included. 54 right breasts and 55 left 
breasts were simulated. V90% was statistically different in PP and SP 
with respectively 96.9% and 98.5% (p= 9.38E-6). PTVs max dose was 
not significantly higher in PP (PP 106.5% vs. SP 106.3%; p= 0.28) Heart 
mean dose was 2.5 % in PP and 1.6% in SP (p= 8.19E-12). Ipsilateral 
lung mean dose was significantly lower in PP (PP 2.2% vs. SP 8.6%; p= 
2.81 E-44). Percentage of ipsilateral lung receiving 20 Gy (V20Gy) was 
0.5% in PP vs. 6.8% in SP (p= 3.47E-43). 
Conclusions: PP is the best position to spare ipsilateral lung and not 
increases hot spots in the PTV. SP achieved a better coverage of the 
PTV at the expense of increased dose near skin. PP was considered 
optimal in 38 of 54 right breasts and in 26 of 55 left breasts.  
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Purpose/Objective: Pre- and posthydration during chemoradiotherapy 
of head and neck cancer administers substantial amounts of fluid 
which potentially alters the anatomy of the patient. The aim of this 
study was to determine the geometric changes of parotid glands as 
function of pre- and posthydration during chemoradiotherapy. 
Materials and Methods: A total of 38 patients were included in this 
retrospective study: 1) an experimental group (n = 19) receiving 
chemoradiotherapy, 2) a control group (n = 19) receiving radiotherapy 
only. Patients in the experimental group received cisplatin with pre- 
and posthydration during the first, fourth and seventh week of the 
treatment. For each cycle of cisplatin, 9 litres of saline solution was 
administrated intravenously to the patient. For each patient, the 
delineations of the parotid glands on the planning CT were 
automatically propagated to the daily Cone Beam CT (CBCT) scans 
through deformable image registration. Volume and position of the 
parotid glands on the CBCT scans were compared to the planning CT 
scan to calculate relative volume and position. Relative volume and 
position of the parotid glands during and after pre- and posthydration 
were compared with the start of prehydration, resulting in ΔV and ΔX 
values. The T-test with significance level α = 0.05 was used to 
compare difference between the groups. 
Results: By week six of the treatment, the mean parotid gland volume 
loss in the experimental group was 22% ± 11% (1 SD), and in the 
control group 24% ± 9%. At the same time point, the mean medial 
distance between the parotid glands decreased by 0.41 cm ± 0.20 cm 
in the experimental group and 0.51 cm ± 0.25 cm in the control group. 
No significant difference between the two groups was demonstrated 
for these general trends. 
However, when pre- and posthydration was administrated, the volume 
of the parotid glands temporarily increased and the position shifted to 
a more lateral position (figure 1). After starting prehydration (day 
zero) the relative change in volume of the parotid glands ΔV was 
significantly different between groups with 7.2% on the first day (p < 
0.001), 9.9% on the second day (p < 0.001) and 5.6% on the third day 
(p = 0.039). The relative change in position of the parotid glands ΔX 
was significantly different between groups with 1.6 mm on the first 
day (p = 0.001) and 2.0 mm on the second day (p < 0.001) after 
starting prehydration. 
 
 Conclusions: Pre- and posthydration during chemoradiotherapy has a 
significant influence on the geometry of the parotid glands. Within the 
context of adaptive radiotherapy, rescanning for replanning during 
pre- and posthydration is not advisable. 
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Purpose/Objective: The purpose of this study is to investigate the 
dosimetric characteristics of volumetric modulated arc radiotherapy 
(VMAT) with flattening filter-free (FFF) beams and assess the role of 
VMAT in the treatment of advanced nasopharyngeal carcinoma (NPC). 
Materials and Methods: Ten cases of CT data were randomly selected 
from advanced NPC patients. Three treatment plans were performed 
for each patient, FFF RapidArc (RA-FFF), conventional RapidArc (RA) 
and static gantry intensity modulated radiation therapy (IMRT). All of 
the plans were generated to meet the same objectives with 7000 cGy 
covering 95% of the PTV70. The doses to the planning target volumes 
(PTVs), organs at risk (OARs) and normal tissue were compared. All 
the plans were delivered on a Varian TrueBeam linear accelerator and 
verified using the Delta4 phantom. The technical delivery parameters 
including the mean gamma score, treatment delivery time and 
monitor units (MUs) were also analyzed. 
Results: All the techniques delivered adequate doses to the PTVs. 
IMRT demonstrated the highest percentage of target coverage (TC) for 
PTV60. For PTV66, RA delivered the lowest mean dose whereas IMRT 
delivered the highest mean dose. For PTV70, RA-FFF provided for 
higher maximum dose and mean dose than other techniques and gave 
the highest homogeneity index (HI). For larynx, RA delivered the 
lowest mean dose of 3183±269cGy, whereas IMRT delivered the 
highest mean dose of 3540±190cGy. For other OAR parameters, no 
significant difference among the different techniques could be 
established. Gamma analysis produced an average pass rate of 
0.985±0.010, 0.985±0.013 and 0.987±0.010 at the 3%/3mm levels for 
RA-FFF, RA and IMRT, respectively. Significant differences in the MUs 
were observed among the three techniques (p=0.000). The delivery 
time for RA-FFF and RA was 152±7s, 153±7s, respectively, which was 
reduced by nearly 70% compared to that of IMRT with the mean time 
of 493±24s.  
 
